ISO 35001:2019 Biorisk management for laboratories and other related organisations

/ ISO 35001:2019 Biorisk management for laboratories and other related organisations, New Items / By

ISO 35001:2019, titled “Biorisk management for laboratories and other related organisations,” provides a framework for managing risks associated with biological agents and materials in a laboratory or similar setting. Here’s a breakdown of the key elements:

1. Scope

  • Purpose: Specifies requirements for a biorisk management system (BRMS) to manage risks related to biological agents and materials, ensuring safety and compliance.
  • Applicability: Suitable for laboratories, research facilities, and other organizations handling biological materials.

2. Normative References

  • Lists other documents that are essential for understanding and implementing the standard, such as ISO 9001 (Quality Management) and ISO 17025 (General requirements for the competence of testing and calibration laboratories).

3. Terms and Definitions

  • Provides definitions for key terms used in the standard, ensuring a common understanding of biorisk management concepts.

4. Context of the Organization

  • Understanding the Organization and Its Context: Identifies external and internal factors affecting biorisk management.
  • Understanding the Needs and Expectations of Interested Parties: Considers the requirements and expectations of stakeholders.
  • Determining the Scope of the BRMS: Defines the boundaries and applicability of the BRMS.
  • BRMS: Establishes, implements, and maintains a BRMS within the defined scope.

5. Leadership

  • Leadership and Commitment: Requires top management to be actively involved in and accountable for the BRMS.
  • Biorisk Management Policy: Establishes a policy outlining the organization’s commitment to managing biorisks.
  • Organizational Roles, Responsibilities, and Authorities: Defines roles and responsibilities for managing biorisks.

6. Planning

  • Actions to Address Risks and Opportunities: Identifies and addresses risks and opportunities related to biorisk management.
  • Biorisk Management Objectives and Planning to Achieve Them: Sets objectives and plans to achieve them.

7. Support

  • Resources: Provides resources necessary for the effective implementation of the BRMS.
  • Competence: Ensures personnel have the necessary skills and knowledge.
  • Awareness: Raises awareness among employees about biorisk management.
  • Communication: Establishes communication channels regarding biorisk management.
  • Documented Information: Manages documents and records related to the BRMS.

8. Operation

  • Operational Planning and Control: Manages processes and controls to mitigate biorisks.
  • Contingency Planning: Develops plans for emergencies and unexpected situations.

9. Performance Evaluation

  • Monitoring, Measurement, Analysis, and Evaluation: Assesses the performance of the BRMS.
  • Internal Audit: Conducts regular audits to ensure compliance with the standard.
  • Management Review: Reviews the BRMS to ensure its effectiveness and make improvements.

10. Improvement

  • Nonconformity and Corrective Action: Addresses nonconformities and takes corrective actions.
  • Continual Improvement: Continually improves the BRMS based on performance evaluations and feedback.

This standard aims to enhance the safety of laboratory environments and other facilities handling biological agents by providing a structured approach to managing biorisks.

What is required ISO 35001:2019 Biorisk management for laboratories and other related organisations

ISO 35001:2019 outlines several requirements for establishing, implementing, maintaining, and continually improving a biorisk management system (BRMS). Here’s a summary of these requirements:

1. Scope and Context

  • Scope Definition: Define the scope of the BRMS, including boundaries and applicability within the organization.
  • Understanding the Organization and Its Context: Identify internal and external issues relevant to the organization’s ability to manage biorisks effectively.
  • Understanding the Needs and Expectations of Interested Parties: Determine the needs and expectations of stakeholders, including regulatory requirements and other obligations.

2. Leadership and Commitment

  • Leadership and Engagement: Top management must actively support and be accountable for the BRMS.
  • Biorisk Management Policy: Establish a policy that demonstrates the organization’s commitment to managing biorisks.
  • Roles, Responsibilities, and Authorities: Define and communicate roles, responsibilities, and authorities related to biorisk management.

3. Planning

  • Risk and Opportunity Management: Identify risks and opportunities related to the BRMS and plan actions to address them.
  • Biorisk Management Objectives: Set specific, measurable objectives for biorisk management and plan how to achieve them.

4. Support

  • Resources: Provide necessary resources (human, technological, financial) for the effective operation of the BRMS.
  • Competence: Ensure that personnel involved in biorisk management are competent, with appropriate qualifications and training.
  • Awareness: Raise awareness among staff about the importance of biorisk management.
  • Communication: Establish processes for effective internal and external communication about biorisks.
  • Documented Information: Manage documentation and records to support the BRMS, including policies, procedures, and records of compliance.

5. Operation

  • Operational Planning and Control: Implement processes to manage biorisks effectively, including controls and procedures.
  • Contingency Planning: Develop and maintain plans for dealing with emergencies and unexpected situations related to biological risks.

6. Performance Evaluation

  • Monitoring and Measurement: Regularly monitor and measure the performance of the BRMS to ensure it is effective and achieving its objectives.
  • Internal Audits: Conduct audits to evaluate the BRMS’s compliance with ISO 35001:2019 and identify areas for improvement.
  • Management Review: Top management must review the BRMS periodically to ensure its continued suitability and effectiveness.

7. Improvement

  • Nonconformity and Corrective Action: Address any nonconformities that arise and take corrective actions to prevent recurrence.
  • Continual Improvement: Use performance evaluations, feedback, and other information to continually improve the BRMS.

By adhering to these requirements, organizations can effectively manage biorisks, enhance safety, and ensure compliance with relevant regulations and standards.

Who is required ISO 35001:2019 Biorisk management for laboratories and other related organisations

ISO 35001:2019 is relevant for various types of organizations involved in handling biological agents and materials. The standard is primarily aimed at:

1. Laboratories

  • Research Laboratories: Laboratories involved in scientific research that handle biological materials, such as those in universities or private research institutions.
  • Clinical Laboratories: Laboratories that conduct diagnostic testing and analysis involving biological samples.
  • Diagnostic Laboratories: Facilities that perform tests on samples to diagnose diseases or conditions.

2. Healthcare Facilities

  • Hospitals and Clinics: Facilities that handle biological specimens for patient care and diagnostics.

3. Biotech and Pharmaceutical Companies

  • Biotech Firms: Companies involved in the development and testing of biological products.
  • Pharmaceutical Manufacturers: Organizations that produce and test pharmaceuticals, including biologics.

4. Environmental and Public Health Organizations

  • Environmental Testing Laboratories: Facilities that test environmental samples for biological contaminants.
  • Public Health Laboratories: Agencies involved in monitoring and controlling biological threats to public health.

5. Educational Institutions

  • Universities and Colleges: Institutions with laboratories that conduct biological research or training.

6. Regulatory and Inspection Agencies

  • Regulatory Bodies: Organizations that set standards and regulations for the handling of biological materials.
  • Inspection Agencies: Entities that assess compliance with biorisk management standards.

7. Any Organization Handling Biological Risks

  • Biological Safety Cabinets (BSC) Providers: Companies that design, manufacture, or maintain equipment used in biological safety.
  • Research and Development (R&D) Facilities: Facilities engaged in the development of new biological products or technologies.

Key Personnel and Stakeholders

  • Management: Responsible for establishing, implementing, and maintaining the biorisk management system.
  • Laboratory Personnel: Users of biological materials who need to be trained and aware of biorisk management procedures.
  • Health and Safety Officers: Professionals involved in ensuring compliance with safety standards and regulations.

By implementing ISO 35001:2019, these organizations can systematically manage biorisks to protect their staff, the environment, and public health.

When is required ISO 35001:2019 Biorisk management for laboratories and other related organisations

ISO 35001:2019 is required or beneficial in situations where organizations need to manage biological risks effectively. This standard is applicable when:

1. Handling Biological Agents and Materials

  • Laboratories: Any laboratory working with potentially hazardous biological agents or materials, such as pathogens, toxins, or genetically modified organisms.
  • Healthcare Facilities: Institutions that process biological samples, including blood, tissue, and other specimens for diagnostics or research.

2. Compliance with Regulations and Standards

  • Regulatory Requirements: Organizations must comply with local, national, or international regulations related to the handling of biological materials. ISO 35001:2019 helps meet these regulatory obligations.
  • Accreditation: Facilities seeking accreditation or certification may need to demonstrate adherence to biorisk management standards, which ISO 35001:2019 provides.

3. Risk Management and Safety Enhancement

  • Risk Reduction: Organizations aiming to reduce the risk of exposure to harmful biological agents or materials.
  • Safety Improvements: Facilities looking to improve their safety protocols and protect employees, the environment, and public health.

4. Internal and External Audits

  • Internal Audits: Organizations conducting internal audits to ensure their biorisk management practices are effective and compliant with the standard.
  • External Audits: Organizations undergoing external audits or inspections that require evidence of a robust biorisk management system.

5. Training and Awareness

  • Staff Training: Institutions that need to train staff on biorisk management practices and ensure that all personnel are aware of the risks and safety procedures.

6. Incident Management and Emergency Preparedness

  • Contingency Planning: Facilities needing to develop and implement plans for managing incidents involving biological risks and emergencies.

7. Continuous Improvement

  • Ongoing Improvement: Organizations committed to continually improving their biorisk management practices based on performance evaluations and feedback.

Implementing ISO 35001:2019 is particularly important for organizations in the biotechnology, pharmaceutical, healthcare, and research sectors, as well as any other entity handling biological risks. It provides a structured approach to managing and mitigating risks associated with biological materials.

Where is required ISO 35001:2019 Biorisk management for laboratories and other related organisations

ISO 35001:2019 is required or beneficial in various settings where biological risks are present. The standard applies to:

1. Laboratories

  • Research Laboratories: Facilities engaged in scientific research involving biological agents, including academic and private research institutions.
  • Clinical Laboratories: Labs that conduct diagnostic testing on biological samples, such as blood, urine, and tissue samples.
  • Diagnostic Laboratories: Laboratories involved in the testing and analysis of biological materials for disease diagnosis.

2. Healthcare Facilities

  • Hospitals: Institutions that handle and test biological specimens from patients, including clinical and research hospitals.
  • Clinics: Healthcare centers performing diagnostics and treatments involving biological samples.

3. Biotechnology and Pharmaceutical Companies

  • Biotech Companies: Organizations developing biological products, including vaccines, therapeutics, and diagnostics.
  • Pharmaceutical Manufacturers: Companies involved in producing and testing pharmaceuticals, including biologics and biosimilars.

4. Environmental and Public Health Organizations

  • Environmental Testing Facilities: Labs analyzing environmental samples for biological contaminants or pathogens.
  • Public Health Labs: Agencies monitoring and controlling biological risks to public health, including surveillance and outbreak response.

5. Educational Institutions

  • Universities and Colleges: Institutions with biological research laboratories or programs that involve handling biological agents.

6. Regulatory and Inspection Agencies

  • Regulatory Authorities: Organizations that set and enforce standards for biological safety and handling.
  • Inspection Bodies: Entities responsible for auditing and inspecting facilities to ensure compliance with biorisk management standards.

7. Industrial and Commercial Facilities

  • Biological Safety Cabinet Providers: Companies that design, manufacture, or maintain equipment used in biological safety.
  • R&D Facilities: Research and development centers working with biological materials and requiring robust risk management practices.

8. Any Organization Handling Biological Risks

  • Biological Material Suppliers: Organizations supplying biological materials to laboratories, research institutions, and healthcare facilities.
  • Contract Research Organizations (CROs): Companies conducting research on behalf of other organizations involving biological agents.

Implementing ISO 35001:2019 helps ensure that these facilities manage biorisks effectively, maintain safety standards, and comply with regulatory requirements. It provides a comprehensive framework for identifying, assessing, and mitigating risks associated with biological materials.

How is required ISO 35001:2019 Biorisk management for laboratories and other related organisations

Implementing ISO 35001:2019 involves several steps to ensure that biorisk management is effectively integrated into an organization’s operations. Here’s how to approach the implementation of this standard:

1. Establishing a Biorisk Management System (BRMS)

  • Define the Scope: Determine the boundaries and applicability of the BRMS within the organization.
  • Identify Context: Understand internal and external factors that affect biorisk management, including regulatory requirements and stakeholder expectations.

2. Leadership and Commitment

  • Top Management Involvement: Secure commitment from top management to support and oversee the BRMS.
  • Develop a Biorisk Management Policy: Create a policy that outlines the organization’s commitment to managing biorisks and achieving its objectives.

3. Risk Assessment and Planning

  • Risk Identification and Assessment: Identify potential biological risks and assess their impact and likelihood.
  • Risk Mitigation Planning: Develop strategies and controls to address identified risks and opportunities.
  • Set Objectives: Define specific, measurable objectives for biorisk management and establish plans to achieve them.

4. Resource Management

  • Allocate Resources: Provide necessary resources (human, technological, financial) for effective BRMS implementation.
  • Ensure Competence: Train personnel involved in biorisk management to ensure they have the required knowledge and skills.

5. Documentation and Communication

  • Documented Information: Develop and maintain documentation related to the BRMS, including procedures, records, and policies.
  • Effective Communication: Establish communication channels to ensure relevant information about biorisk management is shared within the organization and with external stakeholders.

6. Operational Control

  • Implement Controls: Apply operational controls to manage biological risks, including safety procedures, containment measures, and protective equipment.
  • Develop Contingency Plans: Prepare plans for managing emergencies and unexpected incidents related to biological risks.

7. Monitoring and Performance Evaluation

  • Monitor Performance: Regularly monitor and measure the performance of the BRMS to ensure it is functioning effectively.
  • Conduct Internal Audits: Perform internal audits to assess compliance with ISO 35001:2019 and identify areas for improvement.
  • Management Review: Conduct periodic reviews by top management to evaluate the effectiveness of the BRMS and make necessary adjustments.

8. Improvement

  • Address Nonconformities: Identify and correct any nonconformities that arise in the BRMS.
  • Continual Improvement: Use feedback and performance data to continually improve the BRMS and enhance its effectiveness.

Steps for Implementation

  1. Initial Assessment: Evaluate current practices against ISO 35001:2019 requirements.
  2. Develop a Plan: Create a detailed implementation plan, including timelines and responsibilities.
  3. Train Staff: Provide training on biorisk management practices and the requirements of the standard.
  4. Implement Controls: Put in place necessary controls and procedures for managing biological risks.
  5. Monitor and Review: Regularly assess the performance of the BRMS and review its effectiveness.
  6. Document and Report: Maintain detailed documentation and report on the BRMS performance and improvements.

Following these steps ensures that the organization effectively manages biological risks, complies with relevant regulations, and maintains a safe working environment.

Case Study on ISO 35001:2019 Biorisk management for laboratories and other related organisations

Here’s a hypothetical case study illustrating the implementation of ISO 35001:2019 in a research laboratory setting:

Case Study: Implementation of ISO 35001:2019 in BioResearch Labs

Background

BioResearch Labs is a biotechnology company specializing in research on infectious diseases. The company handles various biological agents, including pathogens and genetically modified organisms (GMOs). Due to the nature of their work, ensuring the safety of their staff and compliance with regulatory requirements is critical.

Challenges

  1. Compliance with Regulations: BioResearch Labs needed to ensure compliance with national and international regulations regarding biological risk management.
  2. Risk Identification: Identifying and managing the diverse risks associated with handling infectious agents and GMOs.
  3. Training and Competence: Ensuring that all staff members were adequately trained and competent in biorisk management practices.

Implementation Process

  1. Establishing the Scope and Context
    • Scope: The BRMS was defined to cover all laboratory activities involving biological agents and GMOs.
    • Context Analysis: The organization assessed internal factors (such as existing procedures and resources) and external factors (including regulatory requirements and stakeholder expectations).
  2. Leadership and Commitment
    • Management Support: Top management committed to the BRMS by allocating resources and appointing a Biorisk Management Coordinator.
    • Policy Development: A biorisk management policy was established outlining the organization’s commitment to safety and regulatory compliance.
  3. Risk Assessment and Planning
    • Risk Identification: The laboratory conducted a thorough risk assessment to identify potential hazards related to biological agents and GMOs.
    • Risk Mitigation: Implemented controls such as biosafety cabinets, personal protective equipment, and secure storage for hazardous materials.
    • Objective Setting: Set objectives to reduce incidents involving biological agents by 20% within one year.
  4. Resource Management
    • Resource Allocation: Provided necessary resources, including updated equipment and facilities.
    • Competence: Developed a training program to ensure all staff were knowledgeable about biorisk management procedures and emergency response.
  5. Documentation and Communication
    • Documentation: Created comprehensive documentation, including risk assessment reports, safety procedures, and training records.
    • Communication: Established channels for communicating biorisk management information internally and externally.
  6. Operational Control
    • Procedures: Implemented standard operating procedures (SOPs) for handling biological agents, including protocols for contamination and decontamination.
    • Contingency Planning: Developed and tested emergency response plans for incidents involving biological materials.
  7. Monitoring and Performance Evaluation
    • Monitoring: Regularly monitored the effectiveness of safety measures through inspections and performance metrics.
    • Internal Audits: Conducted quarterly internal audits to assess compliance with ISO 35001:2019.
    • Management Review: Held annual reviews by top management to evaluate the performance of the BRMS and identify areas for improvement.
  8. Improvement
    • Nonconformities: Addressed any issues identified during audits, such as equipment malfunctions or procedural deviations, by implementing corrective actions.
    • Continual Improvement: Used audit findings, incident reports, and feedback from staff to make ongoing improvements to the BRMS.

Results

  • Enhanced Safety: The implementation of ISO 35001:2019 led to improved safety protocols and reduced the number of incidents involving biological materials.
  • Regulatory Compliance: The laboratory achieved compliance with relevant regulations, avoiding potential fines and legal issues.
  • Increased Awareness: Staff became more aware of biorisk management practices, leading to a safer working environment.
  • Continuous Improvement: Regular reviews and audits ensured that the BRMS remained effective and adapted to new risks and changes in regulations.

Conclusion

By implementing ISO 35001:2019, BioResearch Labs successfully enhanced its biorisk management practices, ensuring the safety of its staff and compliance with regulatory requirements. The structured approach provided by the standard facilitated effective risk management and continuous improvement, contributing to the overall success of the laboratory’s operations.

White Paper on ISO 35001:2019 Biorisk management for laboratories and other related organisations

Executive Summary

ISO 35001:2019 provides a comprehensive framework for managing biorisks in laboratories and other organizations handling biological materials. This standard is essential for ensuring safety, regulatory compliance, and effective risk management in environments where biological risks are present. This white paper explores the key aspects of ISO 35001:2019, its importance, and its implementation in various settings.

Introduction

Biological materials, including pathogens and genetically modified organisms (GMOs), pose significant risks in laboratory and research environments. Effective biorisk management is crucial to protect personnel, the environment, and public health. ISO 35001:2019 offers guidelines for establishing, implementing, and maintaining a robust biorisk management system (BRMS) to address these challenges.

Key Aspects of ISO 35001:2019

  1. Scope and Applicability
    • Scope: ISO 35001:2019 applies to organizations involved in handling biological agents and materials, including research laboratories, clinical labs, healthcare facilities, and biotech companies.
    • Applicability: The standard is relevant for any organization managing biological risks, regardless of size or complexity.
  2. Leadership and Commitment
    • Top Management Role: Effective implementation requires strong leadership and commitment from top management. This includes establishing a biorisk management policy and ensuring adequate resources and support.
    • Policy Development: A clear biorisk management policy must outline the organization’s commitment to safety and compliance.
  3. Risk Assessment and Planning
    • Risk Identification: Organizations must identify and assess potential biological risks associated with their activities.
    • Mitigation Strategies: Develop and implement control measures to mitigate identified risks and address potential opportunities for improvement.
    • Objective Setting: Set specific, measurable objectives for biorisk management and develop plans to achieve them.
  4. Resource Management
    • Allocation of Resources: Ensure that necessary resources (financial, human, technological) are available for effective BRMS implementation.
    • Competence and Training: Provide training and ensure that personnel are competent in handling biological materials and following safety procedures.
  5. Documentation and Communication
    • Documented Information: Maintain comprehensive documentation, including procedures, risk assessments, and training records.
    • Communication: Establish effective communication channels for disseminating information related to biorisk management within the organization and with external stakeholders.
  6. Operational Control
    • Implementation of Controls: Apply operational controls to manage risks, including safety procedures, containment measures, and protective equipment.
    • Contingency Planning: Develop and test emergency response plans to handle incidents involving biological materials.
  7. Performance Evaluation
    • Monitoring and Measurement: Regularly monitor and measure the performance of the BRMS to ensure its effectiveness.
    • Internal Audits: Conduct internal audits to assess compliance with the standard and identify areas for improvement.
    • Management Review: Perform periodic reviews by top management to evaluate the BRMS and make necessary adjustments.
  8. Continuous Improvement
    • Nonconformity Management: Address any nonconformities identified and take corrective actions to prevent recurrence.
    • Ongoing Improvement: Use performance data, feedback, and audit results to continually improve the BRMS.

Importance of ISO 35001:2019

  • Safety: Provides a structured approach to managing biological risks, enhancing the safety of personnel, the environment, and public health.
  • Compliance: Helps organizations meet regulatory requirements and avoid potential legal issues.
  • Efficiency: Streamlines processes and improves the effectiveness of risk management practices.
  • Reputation: Demonstrates a commitment to high standards of safety and risk management, enhancing the organization’s reputation.

Implementation Strategies

  1. Initial Assessment: Evaluate current biorisk management practices against ISO 35001:2019 requirements.
  2. Develop a Plan: Create a detailed implementation plan, including timelines, responsibilities, and resource allocation.
  3. Train Personnel: Provide comprehensive training to staff on biorisk management practices and the requirements of the standard.
  4. Implement Controls: Put in place necessary controls and procedures for managing biological risks.
  5. Monitor and Review: Regularly assess the performance of the BRMS and review its effectiveness.
  6. Document and Report: Maintain detailed documentation and report on the BRMS performance and improvements.

Case Study Example

BioResearch Labs: A biotechnology company implementing ISO 35001:2019 enhanced its safety protocols, achieved regulatory compliance, and improved staff awareness. The structured approach provided by the standard led to a significant reduction in incidents involving biological materials and demonstrated a commitment to high safety standards.

Conclusion

ISO 35001:2019 is a critical standard for organizations handling biological materials, offering a comprehensive framework for managing biorisks effectively. By implementing this standard, organizations can improve safety, ensure regulatory compliance, and enhance overall risk management practices.

Recommendations

  • Adopt ISO 35001:2019: Organizations involved in biological risk management should adopt the standard to enhance safety and compliance.
  • Invest in Training: Ensure that all personnel are adequately trained and aware of biorisk management practices.
  • Continuously Improve: Regularly review and update the BRMS to adapt to new risks and changes in regulations.

For more information on ISO 35001:2019 and its implementation, consult the full standard and seek guidance from experts in biorisk management.

Translate »
× How can I help you?
Exit mobile version